Evidence map›Paper›PMID 33101867›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2020

Radiation Dose-Enhancement Is a Potent Radiotherapeutic Effect of Rare-Earth Composite Nanoscintillators in Preclinical Models of Glioblastoma.

Anne-Laure Bulin, Mans Broekgaarden, Frédéric Chaput, Victor Baisamy, Jan Garrevoet, Benoît Busser, Dennis Brueckner, Antonia Youssef, Jean-Luc Ravanat, Christophe Dujardin and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. A BiInternational journal of nanomedicine · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Biomaterial-basedCancer pathogenesis and therapy · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Anne-Laure BulinSynchrotron Radiation for Biomedical Research (STROBE) UA7 INSERM Université Grenoble Alpes Medical Beamline at the European Synchrotron Radiation Facility 71 Avenue des Martyrs Grenoble Cedex 9 38043 France.ORCID https://orcid.org/0000-0002-2644-8626
Mans BroekgaardenSynchrotron Radiation for Biomedical Research (STROBE) UA7 INSERM Université Grenoble Alpes Medical Beamline at the European Synchrotron Radiation Facility 71 Avenue des Martyrs Grenoble Cedex 9 38043 France.ORCID https://orcid.org/0000-0002-9516-5048
Frédéric ChaputUniversité de Lyon École Normale Supérieure de Lyon CNRS UMR 5182 Université Claude Bernard Lyon 1 Laboratoire de Chimie Lyon F69342 France.
Victor BaisamySynchrotron Radiation for Biomedical Research (STROBE) UA7 INSERM Université Grenoble Alpes Medical Beamline at the European Synchrotron Radiation Facility 71 Avenue des Martyrs Grenoble Cedex 9 38043 France.
Jan GarrevoetDeutsches Elektronen-Synchrotron DESY Notkestrasse 85 Hamburg DE-22607 Germany.ORCID https://orcid.org/0000-0001-8696-0499
Benoît BusserCancer Targets and Experimental Therapeutics Institute for Advanced Biosciences Université Grenoble Alpes INSERM U1209 CNRS UMR5309 Allée des Alpes La Tronche 38700 France.ORCID https://orcid.org/0000-0002-9425-1577
Dennis BruecknerDeutsches Elektronen-Synchrotron DESY Notkestrasse 85 Hamburg DE-22607 Germany.
Antonia YoussefSynchrotron Radiation for Biomedical Research (STROBE) UA7 INSERM Université Grenoble Alpes Medical Beamline at the European Synchrotron Radiation Facility 71 Avenue des Martyrs Grenoble Cedex 9 38043 France.
Jean-Luc RavanatUniversité Grenoble Alpes CEA CNRS IRIG SyMMES UMR 5819 Grenoble F-38000 France.ORCID https://orcid.org/0000-0002-7123-6358
Christophe DujardinInstitut Lumière Matière UMR5306 Université Claude Bernard Lyon 1 CNRS Villeurbanne Cedex 69622 France.ORCID https://orcid.org/0000-0002-0205-9837
Vincent Motto-RosInstitut Lumière Matière UMR5306 Université Claude Bernard Lyon 1 CNRS Villeurbanne Cedex 69622 France.ORCID https://orcid.org/0000-0001-6063-5532
Frédéric LerougeUniversité de Lyon École Normale Supérieure de Lyon CNRS UMR 5182 Université Claude Bernard Lyon 1 Laboratoire de Chimie Lyon F69342 France.
Sylvain BohicSynchrotron Radiation for Biomedical Research (STROBE) UA7 INSERM Université Grenoble Alpes Medical Beamline at the European Synchrotron Radiation Facility 71 Avenue des Martyrs Grenoble Cedex 9 38043 France.ORCID https://orcid.org/0000-0001-6355-7592
Lucie SanceyCancer Targets and Experimental Therapeutics Institute for Advanced Biosciences Université Grenoble Alpes INSERM U1209 CNRS UMR5309 Allée des Alpes La Tronche 38700 France.ORCID https://orcid.org/0000-0002-0084-3775
Hélène ElleaumeSynchrotron Radiation for Biomedical Research (STROBE) UA7 INSERM Université Grenoble Alpes Medical Beamline at the European Synchrotron Radiation Facility 71 Avenue des Martyrs Grenoble Cedex 9 38043 France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To improve the prognosis of glioblastoma, innovative radiotherapy regimens are required to augment the effect of tolerable radiation doses while sparing surrounding tissues. In this context, nanoscintillators are emerging radiotherapeutics that down-convert X-rays into photons with energies ranging from UV to near-infrared. During radiotherapy, these scintillating properties amplify radiation-induced damage by UV-C emission or photodynamic effects. Additionally, nanoscintillators that contain high-Z elements are likely to induce another, currently unexplored effect: radiation dose-enhancement. This phenomenon stems from a higher photoelectric absorption of orthovoltage X-rays by high-Z elements compared to tissues, resulting in increased production of tissue-damaging photo- and Auger electrons. In this study, Geant4 simulations reveal that rare-earth composite LaF

Indexed as

glioblastomananoscintillatorsradiation dose‐enhancementsynchrotron radiationX‐ray‐induced photodynamic therapy

Identifiers

PMID33101867
PMCPMC7578894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.